Scholar Rock Holding Corporation (FRA:2QK)

Market Cap	3.95B
Revenue (ttm)	n/a
Net Income (ttm)	-301.23M
Shares Out	n/a
EPS (ttm)	-3.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	19
Open	38.40
Previous Close	37.00
Day's Range	38.40 - 38.40
52-Week Range	21.20 - 46.00
Beta	n/a
RSI	66.08
Earnings Date	Feb 27, 2026

About Scholar Rock Holding

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFβ) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2012
• Employees: 128
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2QK

Financial Performance

Financial numbers in USD